Herbal formula for fatty liver with spleen deficiency damp-heat
Part of Digestive system clinical trials.
This study tests a Chinese herbal formula called Longqi Jiangzhi Decoction for people with non-alcoholic fatty liver disease (NAFLD) who also have a Traditional Chinese Medicine pattern of 'Spleen Deficiency with Damp-Heat'. If you qualify, you will receive the herbal decoction to see if it can reduce liver fat and improve your health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have been diagnosed with non-alcoholic fatty liver disease (NAFLD).
- You have a specific Traditional Chinese Medicine pattern called 'Spleen Deficiency and Damp-Heat' (symptoms like bloating, fatigue, loose stools, and feeling heavy or hot).
- Your liver fat measurement (CAP) is at least 238 dB/m and your body mass index (BMI) is 23 or higher.
- You have not taken any NAFLD medications in the past month.
- Your heart, kidneys, and liver are working normally (based on blood tests and an EKG).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a traditional Chinese herbal capsule (Linzhi Jianghuang Fufang) to treat non-alcoholic fatty liver disease—a buildup of fat in the liver not caused by alcohol. The study aims to see if this herbal treatment can safely reduce liver fat and improve metabolic health in people with early-stage fatty liver.
This trial tests Ganzhixiao capsules for people with MAFLD (a type of fatty liver disease) who also have symptoms of 'damp heat' (like feeling heavy and sluggish). It aims to see if the capsules can help improve liver health.
This study tests whether a traditional Chinese herbal medicine (CXD) combined with a restrictive ketogenic diet can reduce fat buildup in the liver. You may be a good fit if you have fatty liver disease and are interested in trying this combination approach.
This trial tests whether Fuzheng Huayu tablets can help people with fatty liver disease that has progressed to cirrhosis (scarring) that is still compensated (the liver is still working well). The goal is to see if the tablets slow or reverse liver damage.
This study is testing if a combination of four herbs (artichoke, milk thistle, turmeric, and licorice root) can help people with non-alcoholic mild to moderate fatty liver disease (also called metabolic-associated fatty liver disease). It's a randomized trial, meaning participants are assigned to either the herbal mix or a comparison group. This may offer a natural option to support liver health.
This study follows people with fatty liver disease (NAFLD) and a related condition (NASH) to see how it changes over time. It may help researchers understand who is most likely to worsen and what patterns show up as the disease progresses.
Hear when a new Hepatic Steatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.